Alzheimer Dementia

Neurology·MeSH: Dementia

20 drugs in development·1 company·1 clinical trial

Drug Pipeline by Phase

Phase 3(3)

Drug	Company
eflornithine plus sulindac	GH Research PLC (GHRS) Analyze with AI →
high dose il-2	GH Research PLC (GHRS) Analyze with AI →
il-2	GH Research PLC (GHRS) Analyze with AI →

Phase 2(9)

Drug	Company
15 µg h5n1 antigen plus mf59	GH Research PLC (GHRS) Analyze with AI →
15 µg h5n8 antigen plus half dose as03a	GH Research PLC (GHRS) Analyze with AI →
15 µg h5n8 antigen plus mf59	GH Research PLC (GHRS) Analyze with AI →
3.75 µg h5n1 antigen plus mf59	GH Research PLC (GHRS) Analyze with AI →
3.75 µg h5n8 antigen plus half dose as03a	GH Research PLC (GHRS) Analyze with AI →
3.75 µg h5n8 antigen plus mf59	GH Research PLC (GHRS) Analyze with AI →
7.5 µg h5n1 antigen plus mf59	GH Research PLC (GHRS) Analyze with AI →
7.5 µg h5n8 antigen plus half dose as03a	GH Research PLC (GHRS) Analyze with AI →
7.5 µg h5n8 antigen plus mf59	GH Research PLC (GHRS) Analyze with AI →

Phase 1/Phase 2(1)

Drug	Company
semaglutide plus il-2	GH Research PLC (GHRS) Analyze with AI →

Phase 2/Phase 3(7)

Drug	Company
15 µg h5n1 antigen plus full dose as03a	GH Research PLC (GHRS) Analyze with AI →
15 µg h5n8 antigen plus full dose as03a	GH Research PLC (GHRS) Analyze with AI →
3.75 µg h5n1 antigen plus full dose as03a	GH Research PLC (GHRS) Analyze with AI →
3.75 µg h5n8 antigen plus full dose as03a	GH Research PLC (GHRS) Analyze with AI →
7.5 µg h5n1 antigen plus full dose as03a	GH Research PLC (GHRS) Analyze with AI →
7.5 µg h5n8 antigen plus full dose as03a	GH Research PLC (GHRS) Analyze with AI →
dasatinib plus quercetin	GH Research PLC (GHRS) Analyze with AI →

BioSniper tracks 20 drugs in development for Alzheimer Dementia across 1 company.

There are 1 clinical trial targeting Alzheimer Dementia tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.